跳至主要内容
临床试验/CTRI/2025/08/092694
CTRI/2025/08/092694尚未招募2/3 期

Randomized controlled clinical trial to evaluate efficacy of Amrutprabha gutika in the management of Pratishayay with special reference to allergic rhinitis

Dr Vaishnavi Ranganath Patil1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年8月11日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Amrutprabha gutika is effective in the management of Pratishayay

研究概览

简要总结

This study is an open randomized controlled clinical trial to evaluate  efficacy of Amrutprabha gutika in the management of Pratishayay w.s.r. allergic rhinitis. The study will be carried at OPD of Kaumarbhritya department of Late Kedari Redekar Ayurvedic Mahavidyalaya and hospital Gadhinglaj Kolhapur. The observation would be drawn on the basis of symptoms after treatment is given.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
8.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Patients fulfilling clinical features of Pratishayay 2.selection of patients will be irrespective of their sex, religion, socioeconomic status.

排除标准

  • Patients having any congenital deformity
  • Patients having nasal polyp, sinusitis, rhinorrhea due to foreign body or trauma, DNS
  • Patients having lower respiratory tract infection.

结局指标

主要结局

Amrutprabha gutika is effective in the management of Pratishayay

时间窗: Initial assessment at 0 day | Follow up at 3rd day and 5th day | Final assessment at 7th day

次要结局

  • Amrutprabha gutika is effective than tablet levocetirizine in the management of Pratishayay(Initial assessment at 0 day)

研究者

发起方
Dr Vaishnavi Ranganath Patil
申办方类型
Other [Self ]
责任方
Principal Investigator
主要研究者

Dr Vaishnavi Ranganath Patil

Late Kedari Redekar Ayurvedic Mahavidyalaya Gadhinglaj Kolhapur

研究点 (1)

Loading locations...

相似试验